The Wall of Remembrance
Father? Husband?
Son? Best mate?
You can remember a friend or relative on this site by adding your message to our unique Wall of Remembrance
Click here to contribute.
Prostate cancer worries?
Concerned about prostate cancer?
An overview of the disease, symptoms, tests and related useful information.
Helping the Prostate Cancer Research Foundation
Make a donation to the William Franklyn Memorial Fund.
Information on how to help the Prostate Cancer Research Foundation, including donating online, organising your own events and leaving a legacy.
Funded Research 2004
Is the PI3K/Akt pathway involved in the development of hormone refractory prostate cancer?
Dr Joanne Edwards, Division of Cancer Studies and Molecular Pathology, University Department of Surgery, The University of Glasgow
Dr Joanne Edwards and PCRF funded research technician,
Pamela Traynor
The object of this project is to investigate whether the PI3K/Akt pathway is involved in the development of AIPC in human prostate cancer specimens.
Data obtained from this project will allow us to determine if an increase in Akt activity is related to the development of clinical AIPC, by comparing protein expression levels in paired androgen sensitive and androgen resistant tumours. Protein expression levels will also be correlated with Gleason sum, time to relapse and time to death from relapse. It is only by unpicking the molecular mechanisms responsible for the development of AIPC that we are going to be able to prolong survival of prostate cancer patients. By understanding the route by which AIPC occurs we will identify suitable therapeutic targets, of which many may already have drugs available. By increasing our knowledge about the development of AIPC we are hoping to move towards profiling treatment for individual patients according to the route by which AIPC has developed in their tumour.
Publications
Clinical Cancer Research, February 2006
www.aacrjournals.org
Project commenced
June 2004
Length of project
1 year
Amount Supported
£24,276
